The global Enzyme-Linked Immunosorbent Assay (ELISA) Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

From a downstream perspective, Disease Diagnosis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Enzyme-Linked Immunosorbent Assay (ELISA) Service leading manufacturers including Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc, R&D Systems, Inc, ProteoGenix, etc., dominate supply; the top five capture approximately % of global revenue, with Virology Research Services Ltd leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Report

Report Metric	Details
Report Name	Enzyme-Linked Immunosorbent Assay (ELISA) Service Market
Segment by Type	Routine ELISA Assays Targeted Assay Development
Segment by Application	Disease Diagnosis Vaccine Effectiveness Evaluation Drug Development Allergen Testing Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc, R&D Systems, Inc, ProteoGenix, Eve Technologies, NorthEast BioAnalytical Laboratories LLC, mabtech, Pestka Biomedical Laboratories, Inc, Thermo Fisher Scientific, Antibodies Incorporated, Kaneka Eurogentec S.A
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Enzyme-Linked Immunosorbent Assay (ELISA) Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Enzyme-Linked Immunosorbent Assay (ELISA) Service Market report?

Ans: The main players in the Enzyme-Linked Immunosorbent Assay (ELISA) Service Market are Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc, R&D Systems, Inc, ProteoGenix, Eve Technologies, NorthEast BioAnalytical Laboratories LLC, mabtech, Pestka Biomedical Laboratories, Inc, Thermo Fisher Scientific, Antibodies Incorporated, Kaneka Eurogentec S.A

What are the Application segmentation covered in the Enzyme-Linked Immunosorbent Assay (ELISA) Service Market report?

Ans: The Applications covered in the Enzyme-Linked Immunosorbent Assay (ELISA) Service Market report are Disease Diagnosis, Vaccine Effectiveness Evaluation, Drug Development, Allergen Testing, Others

What are the Type segmentation covered in the Enzyme-Linked Immunosorbent Assay (ELISA) Service Market report?

Ans: The Types covered in the Enzyme-Linked Immunosorbent Assay (ELISA) Service Market report are Routine ELISA Assays, Targeted Assay Development

1 Study Coverage

1.1 Introduction to Enzyme-Linked Immunosorbent Assay (ELISA) Service: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Routine ELISA Assays

1.2.3 Targeted Assay Development

1.3 Market Segmentation by Application

1.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Disease Diagnosis

1.3.3 Vaccine Effectiveness Evaluation

1.3.4 Drug Development

1.3.5 Allergen Testing

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Estimates and Forecasts 2020-2031

2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Routine ELISA Assays Market Size by Players

3.3.2 Targeted Assay Development Market Size by Players

3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type (2020-2031)

6.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type (2020-2031)

7.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type (2020-2031)

8.4 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type (2020-2031)

9.4 Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type (2020-2031)

10.4 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Virology Research Services Ltd

11.1.1 Virology Research Services Ltd Corporation Information

11.1.2 Virology Research Services Ltd Business Overview

11.1.3 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.1.4 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.1.5 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Product in 2024

11.1.6 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application in 2024

11.1.7 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Geographic Area in 2024

11.1.8 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

11.1.9 Virology Research Services Ltd Recent Developments

11.2 ACROBiosystems

11.2.1 ACROBiosystems Corporation Information

11.2.2 ACROBiosystems Business Overview

11.2.3 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.2.4 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.2.5 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Product in 2024

11.2.6 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application in 2024

11.2.7 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Geographic Area in 2024

11.2.8 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

11.2.9 ACROBiosystems Recent Developments

11.3 Boster Bio

11.3.1 Boster Bio Corporation Information

11.3.2 Boster Bio Business Overview

11.3.3 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.3.4 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.3.5 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Product in 2024

11.3.6 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application in 2024

11.3.7 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Geographic Area in 2024

11.3.8 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

11.3.9 Boster Bio Recent Developments

11.4 RayBiotech, Inc

11.4.1 RayBiotech, Inc Corporation Information

11.4.2 RayBiotech, Inc Business Overview

11.4.3 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.4.4 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.4.5 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Product in 2024

11.4.6 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application in 2024

11.4.7 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Geographic Area in 2024

11.4.8 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

11.4.9 RayBiotech, Inc Recent Developments

11.5 Precision Medicine Group, LLC

11.5.1 Precision Medicine Group, LLC Corporation Information

11.5.2 Precision Medicine Group, LLC Business Overview

11.5.3 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.5.4 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.5.5 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Product in 2024

11.5.6 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application in 2024

11.5.7 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Geographic Area in 2024

11.5.8 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

11.5.9 Precision Medicine Group, LLC Recent Developments

11.6 Bio-Techne

11.6.1 Bio-Techne Corporation Information

11.6.2 Bio-Techne Business Overview

11.6.3 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.6.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.6.5 Bio-Techne Recent Developments

11.7 Cellular Technology Limited（immunospot）

11.7.1 Cellular Technology Limited（immunospot） Corporation Information

11.7.2 Cellular Technology Limited（immunospot） Business Overview

11.7.3 Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.7.4 Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.7.5 Cellular Technology Limited（immunospot） Recent Developments

11.8 Sino Biological, Inc

11.8.1 Sino Biological, Inc Corporation Information

11.8.2 Sino Biological, Inc Business Overview

11.8.3 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.8.4 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.8.5 Sino Biological, Inc Recent Developments

11.9 R&D Systems, Inc

11.9.1 R&D Systems, Inc Corporation Information

11.9.2 R&D Systems, Inc Business Overview

11.9.3 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.9.4 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.9.5 R&D Systems, Inc Recent Developments

11.10 ProteoGenix

11.10.1 ProteoGenix Corporation Information

11.10.2 ProteoGenix Business Overview

11.10.3 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.10.4 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Eve Technologies

11.11.1 Eve Technologies Corporation Information

11.11.2 Eve Technologies Business Overview

11.11.3 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.11.4 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.11.5 Eve Technologies Recent Developments

11.12 NorthEast BioAnalytical Laboratories LLC

11.12.1 NorthEast BioAnalytical Laboratories LLC Corporation Information

11.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview

11.12.3 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.12.4 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments

11.13 mabtech

11.13.1 mabtech Corporation Information

11.13.2 mabtech Business Overview

11.13.3 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.13.4 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.13.5 mabtech Recent Developments

11.14 Pestka Biomedical Laboratories, Inc

11.14.1 Pestka Biomedical Laboratories, Inc Corporation Information

11.14.2 Pestka Biomedical Laboratories, Inc Business Overview

11.14.3 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.14.4 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.14.5 Pestka Biomedical Laboratories, Inc Recent Developments

11.15 Thermo Fisher Scientific

11.15.1 Thermo Fisher Scientific Corporation Information

11.15.2 Thermo Fisher Scientific Business Overview

11.15.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.15.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.15.5 Thermo Fisher Scientific Recent Developments

11.16 Antibodies Incorporated

11.16.1 Antibodies Incorporated Corporation Information

11.16.2 Antibodies Incorporated Business Overview

11.16.3 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.16.4 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.16.5 Antibodies Incorporated Recent Developments

11.17 Kaneka Eurogentec S.A

11.17.1 Kaneka Eurogentec S.A Corporation Information

11.17.2 Kaneka Eurogentec S.A Business Overview

11.17.3 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Features and Attributes

11.17.4 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2020-2025)

11.17.5 Kaneka Eurogentec S.A Recent Developments

12 Enzyme-Linked Immunosorbent Assay (ELISA) ServiceIndustry Chain Analysis

12.1 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Virology Research Services Ltd

ACROBiosystems

Boster Bio

RayBiotech

Precision Medicine Group, LLC

Bio-Techne

Cellular Technology Limited（immunospot）

NorthEast BioAnalytical Laboratories LLC.

Mabtech

Pestka Biomedical Laboratories, Inc.

Thermo Fisher Scientific

Antibodies Incorporated

Kaneka Eurogentec S.A.

List of Tables

Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service as of 2024)

Table 11. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Companies Headquarters

Table 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2026-2031) & (US$ Million)

Table 21. Enzyme-Linked Immunosorbent Assay (ELISA) Service High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Growth Accelerators and Market Barriers

Table 25. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Growth Accelerators and Market Barriers

Table 27. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Investment Opportunities and Key Challenges

Table 31. Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Virology Research Services Ltd Corporation Information

Table 35. Virology Research Services Ltd Description and Major Businesses

Table 36. Virology Research Services Ltd Product Features and Attributes

Table 37. Virology Research Services Ltd Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Virology Research Services Ltd Revenue Proportion by Product in 2024

Table 39. Virology Research Services Ltd Revenue Proportion by Application in 2024

Table 40. Virology Research Services Ltd Revenue Proportion by Geographic Area in 2024

Table 41. Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

Table 42. Virology Research Services Ltd Recent Developments

Table 43. ACROBiosystems Corporation Information

Table 44. ACROBiosystems Description and Major Businesses

Table 45. ACROBiosystems Product Features and Attributes

Table 46. ACROBiosystems Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. ACROBiosystems Revenue Proportion by Product in 2024

Table 48. ACROBiosystems Revenue Proportion by Application in 2024

Table 49. ACROBiosystems Revenue Proportion by Geographic Area in 2024

Table 50. ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

Table 51. ACROBiosystems Recent Developments

Table 52. Boster Bio Corporation Information

Table 53. Boster Bio Description and Major Businesses

Table 54. Boster Bio Product Features and Attributes

Table 55. Boster Bio Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Boster Bio Revenue Proportion by Product in 2024

Table 57. Boster Bio Revenue Proportion by Application in 2024

Table 58. Boster Bio Revenue Proportion by Geographic Area in 2024

Table 59. Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

Table 60. Boster Bio Recent Developments

Table 61. RayBiotech, Inc Corporation Information

Table 62. RayBiotech, Inc Description and Major Businesses

Table 63. RayBiotech, Inc Product Features and Attributes

Table 64. RayBiotech, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. RayBiotech, Inc Revenue Proportion by Product in 2024

Table 66. RayBiotech, Inc Revenue Proportion by Application in 2024

Table 67. RayBiotech, Inc Revenue Proportion by Geographic Area in 2024

Table 68. RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

Table 69. RayBiotech, Inc Recent Developments

Table 70. Precision Medicine Group, LLC Corporation Information

Table 71. Precision Medicine Group, LLC Description and Major Businesses

Table 72. Precision Medicine Group, LLC Product Features and Attributes

Table 73. Precision Medicine Group, LLC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Precision Medicine Group, LLC Revenue Proportion by Product in 2024

Table 75. Precision Medicine Group, LLC Revenue Proportion by Application in 2024

Table 76. Precision Medicine Group, LLC Revenue Proportion by Geographic Area in 2024

Table 77. Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service SWOT Analysis

Table 78. Precision Medicine Group, LLC Recent Developments

Table 79. Bio-Techne Corporation Information

Table 80. Bio-Techne Description and Major Businesses

Table 81. Bio-Techne Product Features and Attributes

Table 82. Bio-Techne Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Bio-Techne Recent Developments

Table 84. Cellular Technology Limited（immunospot） Corporation Information

Table 85. Cellular Technology Limited（immunospot） Description and Major Businesses

Table 86. Cellular Technology Limited（immunospot） Product Features and Attributes

Table 87. Cellular Technology Limited（immunospot） Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Cellular Technology Limited（immunospot） Recent Developments

Table 89. Sino Biological, Inc Corporation Information

Table 90. Sino Biological, Inc Description and Major Businesses

Table 91. Sino Biological, Inc Product Features and Attributes

Table 92. Sino Biological, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Sino Biological, Inc Recent Developments

Table 94. R&D Systems, Inc Corporation Information

Table 95. R&D Systems, Inc Description and Major Businesses

Table 96. R&D Systems, Inc Product Features and Attributes

Table 97. R&D Systems, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. R&D Systems, Inc Recent Developments

Table 99. ProteoGenix Corporation Information

Table 100. ProteoGenix Description and Major Businesses

Table 101. ProteoGenix Product Features and Attributes

Table 102. ProteoGenix Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. ProteoGenix Recent Developments

Table 104. Eve Technologies Corporation Information

Table 105. Eve Technologies Description and Major Businesses

Table 106. Eve Technologies Product Features and Attributes

Table 107. Eve Technologies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Eve Technologies Recent Developments

Table 109. NorthEast BioAnalytical Laboratories LLC Corporation Information

Table 110. NorthEast BioAnalytical Laboratories LLC Description and Major Businesses

Table 111. NorthEast BioAnalytical Laboratories LLC Product Features and Attributes

Table 112. NorthEast BioAnalytical Laboratories LLC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. NorthEast BioAnalytical Laboratories LLC Recent Developments

Table 114. mabtech Corporation Information

Table 115. mabtech Description and Major Businesses

Table 116. mabtech Product Features and Attributes

Table 117. mabtech Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. mabtech Recent Developments

Table 119. Pestka Biomedical Laboratories, Inc Corporation Information

Table 120. Pestka Biomedical Laboratories, Inc Description and Major Businesses

Table 121. Pestka Biomedical Laboratories, Inc Product Features and Attributes

Table 122. Pestka Biomedical Laboratories, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. Pestka Biomedical Laboratories, Inc Recent Developments

Table 124. Thermo Fisher Scientific Corporation Information

Table 125. Thermo Fisher Scientific Description and Major Businesses

Table 126. Thermo Fisher Scientific Product Features and Attributes

Table 127. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. Thermo Fisher Scientific Recent Developments

Table 129. Antibodies Incorporated Corporation Information

Table 130. Antibodies Incorporated Description and Major Businesses

Table 131. Antibodies Incorporated Product Features and Attributes

Table 132. Antibodies Incorporated Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Antibodies Incorporated Recent Developments

Table 134. Kaneka Eurogentec S.A Corporation Information

Table 135. Kaneka Eurogentec S.A Description and Major Businesses

Table 136. Kaneka Eurogentec S.A Product Features and Attributes

Table 137. Kaneka Eurogentec S.A Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Kaneka Eurogentec S.A Recent Developments

Table 139. Raw Materials Key Suppliers

Table 140. Distributors List

Table 141. Market Trends and Market Evolution

Table 142. Market Drivers and Opportunities

Table 143. Market Challenges, Risks, and Restraints

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Picture

Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Routine ELISA Assays Product Picture

Figure 4. Targeted Assay Development Product Picture

Figure 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Disease Diagnosis

Figure 7. Vaccine Effectiveness Evaluation

Figure 8. Drug Development

Figure 9. Allergen Testing

Figure 10. Others

Figure 11. Enzyme-Linked Immunosorbent Assay (ELISA) Service Report Years Considered

Figure 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Region (2020-2031)

Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share Ranking (2024)

Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 18. Routine ELISA Assays Revenue Market Share by Player in 2024

Figure 19. Targeted Assay Development Revenue Market Share by Player in 2024

Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2020-2031)

Figure 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2020-2031)

Figure 22. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY (2020-2031) & (US$ Million)

Figure 23. North America Top 5 Players Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) in 2024

Figure 24. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Type (2020 - 2031)

Figure 25. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Application (2020-2031)

Figure 26. US Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 27. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 28. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 29. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Europe Top 5 Players Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) in 2024

Figure 31. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Type (2020-2031)

Figure 32. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Application (2020-2031)

Figure 33. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 34. France Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 35. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 36. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 37. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Top 8 Players Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) in 2024

Figure 40. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Type (2020-2031)

Figure 41. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Application (2020-2031)

Figure 42. Indonesia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 43. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 44. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 45. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 46. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 47. Indonesia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 48. Vietnam Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 49. Malaysia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 50. Philippines Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 51. Singapore Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2031) & (US$ Million)

Figure 52. Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY (2020-2031) & (US$ Million)

Figure 53. Central and South America Top 5 Players Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) in 2024

Figure 54. Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Type (2020-2031)

Figure 55. Central and South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Application (2020-2031)

Figure 56. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2025) & (US$ Million)

Figure 57. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2025) & (US$ Million)

Figure 58. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY (2020-2031) & (US$ Million)

Figure 59. Middle East and Africa Top 5 Players Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) in 2024

Figure 60. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Type (2020-2031)

Figure 61. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (US$ Million) by Application (2020-2031)

Figure 62. GCC Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2025) & (US$ Million)

Figure 63. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2025) & (US$ Million)

Figure 64. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2025) & (US$ Million)

Figure 65. South Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2020-2025) & (US$ Million)

Figure 66. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Chain Mapping

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37F12574

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8O12834

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions